(secondQuint)A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions.

 Study Type: Interventional Study Design: Randomized, 2-period, 2-sequence, crossover design.

 Official Title: A Randomized, Single Dose Two -Way Crossover Relative Bioavailability Study of Bupropion Extended-Released Tablets Formulation in Fasted, Normal, Healthy Subjects.

 Further study details as provided by Actavis Elizabeth LLC: Primary Outcome Measures: Rate and Extend of Absorption.

 A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions@highlight

The purpose of this study is to compare the rate and extent of absorption of Bupropion HCl extended-release tablet (test) to that of Wellbutrin SR extended-release tablet (reference) after a single, one-tablet (150 mg) dose in fasted subjects.

